These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology. Ishiguro Y; Tsunemi T; Shimada T; Yoroisaka A; Ueno SI; Takeshige-Amano H; Hatano T; Inoue Y; Saiki S; Hattori N Biochem Biophys Res Commun; 2024 Apr; 703():149620. PubMed ID: 38359614 [TBL] [Abstract][Full Text] [Related]
8. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease? Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781 [TBL] [Abstract][Full Text] [Related]
10. Internalization, axonal transport and release of fibrillar forms of alpha-synuclein. Bieri G; Gitler AD; Brahic M Neurobiol Dis; 2018 Jan; 109(Pt B):219-225. PubMed ID: 28323023 [TBL] [Abstract][Full Text] [Related]
11. Potential of extracellular vesicles in the Parkinson's disease - Pathological mediators and biomarkers. Zhao Y; Yang G Neurochem Int; 2021 Mar; 144():104974. PubMed ID: 33485881 [TBL] [Abstract][Full Text] [Related]
12. Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease. Lee SJ J Mol Neurosci; 2008; 34(1):17-22. PubMed ID: 18157654 [TBL] [Abstract][Full Text] [Related]
13. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term. Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768 [TBL] [Abstract][Full Text] [Related]
14. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease. Liu Z; Chan RB; Cai Z; Liu X; Wu Y; Yu Z; Feng T; Yang Y; Zhang J J Neuroinflammation; 2022 Feb; 19(1):53. PubMed ID: 35193594 [TBL] [Abstract][Full Text] [Related]
15. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters. Chistiakov DA; Chistiakov AA Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175 [TBL] [Abstract][Full Text] [Related]
16. Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease. Vella LJ; Hill AF; Cheng L Int J Mol Sci; 2016 Feb; 17(2):173. PubMed ID: 26861304 [TBL] [Abstract][Full Text] [Related]
17. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice. Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553 [TBL] [Abstract][Full Text] [Related]
18. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease. Daher JP Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286 [TBL] [Abstract][Full Text] [Related]
19. Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson's Disease. Scott-Massey A; Boag MK; Magnier A; Bispo DPCF; Khoo TK; Pountney DL Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361716 [TBL] [Abstract][Full Text] [Related]